| scholarly article | Q13442814 |
| P50 | author | Cheng Zhang | Q89439420 |
| Lin Shen | Q92439752 | ||
| P2093 | author name string | Sai Ge | |
| Jing Gao | |||
| Jifang Gong | |||
| Xiaoting Lin | |||
| Wenwen Huang | |||
| Mengqi Zhang | |||
| P2860 | cites work | The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase | Q24299948 |
| ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility | Q24304362 | ||
| N6-methyladenosine-dependent regulation of messenger RNA stability | Q24310545 | ||
| A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation | Q24311871 | ||
| N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions | Q24320088 | ||
| Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq | Q24320240 | ||
| The many faces and functions of β-catenin | Q26865781 | ||
| m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells | Q27303707 | ||
| High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis | Q27930684 | ||
| Inactivation of the Fto gene protects from obesity | Q28235948 | ||
| RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors | Q28241588 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation | Q28511267 | ||
| N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells | Q28585513 | ||
| PI3K and cancer: lessons, challenges and opportunities | Q30080017 | ||
| MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays | Q33248310 | ||
| FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis | Q34448805 | ||
| Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA. | Q34519307 | ||
| Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells | Q34648726 | ||
| The two faces of interferon-γ in cancer | Q35269015 | ||
| High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression | Q35709435 | ||
| RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation | Q35879032 | ||
| Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus | Q37238133 | ||
| Gastric cancer-molecular and clinical dimensions | Q37591176 | ||
| Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells | Q37662078 | ||
| Gastric Cancer Genomics: Advances and Future Directions. | Q37673604 | ||
| Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. | Q38307191 | ||
| m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program | Q38710467 | ||
| Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling | Q38801971 | ||
| Immune checkpoints and their inhibition in cancer and infectious diseases. | Q38845026 | ||
| Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. | Q38941242 | ||
| Immune checkpoints and immunotherapy for colorectal cancer | Q40383388 | ||
| Expression of immunoreactive E-cadherin adhesion molecules in human cancers | Q42050500 | ||
| A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling | Q42323181 | ||
| Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia | Q42324235 | ||
| A new player SETs in myeloid malignancy | Q43123410 | ||
| The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. | Q45067620 | ||
| m6A modulates haematopoietic stem and progenitor cell specification | Q47073270 | ||
| Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer. | Q47324885 | ||
| Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. | Q47352505 | ||
| RNA N6-methyladenosine methyltransferase METTL3 promotes liver cancer progression through YTHDF2 dependent post-transcriptional silencing of SOCS2. | Q47368330 | ||
| Reading m6A in the Transcriptome: m6A-Binding Proteins | Q47440542 | ||
| m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. | Q47583443 | ||
| Rethinking m6A Readers, Writers, and Erasers. | Q48009024 | ||
| PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. | Q48184221 | ||
| E-cadherin: Its dysregulation in carcinogenesis and clinical implications. | Q49570064 | ||
| FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. | Q51236778 | ||
| Wnt signaling in cancer. | Q51518956 | ||
| A proteomic landscape of diffuse-type gastric cancer. | Q52727768 | ||
| Short rare MUC6 minisatellites-5 alleles influence susceptibility to gastric carcinoma by regulating gene. | Q53321692 | ||
| Gastric cancer and Hedgehog signaling pathway: emerging new paradigms. | Q54945791 | ||
| Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway | Q57189797 | ||
| Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control | Q57295433 | ||
| Cross-talk among writers, readers, and erasers of mA regulates cancer growth and progression | Q57298223 | ||
| Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors | Q57796359 | ||
| Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning | Q57990927 | ||
| IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner | Q58106106 | ||
| ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation | Q58116307 | ||
| Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling | Q58704446 | ||
| Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity | Q59349379 | ||
| RNA mA modification enzymes shape innate responses to DNA by regulating interferon β | Q59350385 | ||
| Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer | Q62746983 | ||
| m6A modification controls the innate immune response to infection by targeting type I interferons | Q67200928 | ||
| Expression of E- and P-cadherin in gastric carcinomas | Q70127603 | ||
| Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis | Q73461186 | ||
| Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer | Q74256215 | ||
| Molecular biology of gastric cancer | Q80226247 | ||
| Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia | Q90237358 | ||
| Senescence markers: Predictive for response to checkpoint inhibitors | Q91172519 | ||
| Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways | Q91294547 | ||
| DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas | Q91719964 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 4766-4781 | |
| P577 | publication date | 2019-06-26 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer | |
| P478 | volume | 8 |
| Q98782166 | Construction and validation of a TP53-associated immune prognostic model for gastric cancer |
| Q94601208 | Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma |
| Q94671511 | Diverse molecular functions of m6A mRNA modification in cancer |
| Q90354637 | High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration |
| Q98386343 | Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation |
| Q96640430 | LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression |
| Q104795191 | METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease |
| Q90347515 | METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway |
| Q92541919 | Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers |
| Q92774466 | N6-Methyladenosine: A Potential Breakthrough for Human Cancer |
| Q99709615 | N6-methyladenosine (m6A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules |
| Q91763636 | N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications |
| Q92757486 | RNA N6-methyladenosine modification in solid tumors: new therapeutic frontiers |
| Q98224318 | Reshaping the role of m6A modification in cancer transcriptome: a review |
| Q101573907 | The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene |
| Q90404858 | m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer |
| Q98729616 | m6A RNA methylation impacts fate choices during skin morphogenesis |
| Q92450835 | m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling |
Search more.